RecallDepth
Class II Ongoing

Ranolazine Extended-Release Tablets 500mg, 60 Tablets per bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Plot No. 2, Phase-2, Pharma Zone SEZ, Pithampur Dist - Dhar, Madhya Pradesh - 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-319-60.

This recall is currently active, issued November 15, 2023. It was issued by Glenmark Pharmaceuticals Inc., Usa.

Company
Glenmark Pharmaceuticals Inc., Usa
Recall Initiated
October 23, 2023
Posted
November 15, 2023
Recall Number
D-0092-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
16,944 bottles
Firm Location
Mahwah, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Dissolution Specifications: Out of specification for dissolution.

Distribution

Nationwide

Lot / Code Info

Lot # 17230388, Exp. 01/31/2025

More recalls by Glenmark Pharmaceuticals Inc., Usa

View all recalls by this company →

Other recent Class II Drug recalls